Feature Channels: Respiratory Diseases and Disorders

Filters close
Released: 2-Nov-2021 3:45 PM EDT
Especialista da Mayo Clinic Healthcare discute doenças pulmonares obstrutivas crônicas causadas pelo tabagismo
Mayo Clinic

O Dia Mundial da DPOC é celebrado no dia 17 de novembro. As doença pulmonar obstrutiva crônica (DPOC) é um grupo de doenças pulmonares progressivas, incluindo a bronquite crônica e o enfisema, que dificultam a respiração do paciente. Milhões de pessoas morrem no mundo todo devido à DPOC.

Released: 2-Nov-2021 3:45 PM EDT
خبير مايو كلينك للرعاية الصحية يناقش داء الانسداد الرئوي المزمن الناجم عن الدخان
Mayo Clinic

اليوم العالمي لداء الانسداد الرئوي المزمن هو 17 تشرين الثاني/نوفمبر.— داء الانسداد الرئوي المزمن (COPD) هو مجموعة أمراض رئوية تصاعدية، تشمل التهاب القصبات المُزمن وانتفاخ الرئة، والتي تجعل من الصعب التنفس. ويموت الملايين من الأشخاص حول العالم كل عام بسبب داء الانسداد الرئوي المزمن.

Released: 2-Nov-2021 3:40 PM EDT
Experto de Mayo Clinic Healthcare habla sobre la enfermedad pulmonar obstructiva crónica provocada por el humo
Mayo Clinic

El Día Mundial de la EPOC es el 17 de noviembre. La enfermedad pulmonar obstructiva crónica (EPOC) comprende a un grupo de enfermedades pulmonares progresivas que dificultan la respiración. Millones de personas en todo el mundo mueren anualmente debido a la EPOC.

Released: 2-Nov-2021 2:25 PM EDT
Study Finds Systemic Autoimmune Disease Patients Fare Well After Transplants, Making Surgery a Viable Treatment Option for End-Stage Lung Disease
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with systemic autoimmune diseases do as well after lung or heart-lung transplants as those without any systemic causes of end-stage lung disease.

28-Oct-2021 8:05 AM EDT
Ventilation Matters: Engineering Airflow to Avoid Spreading COVID-19
American Institute of Physics (AIP)

As we approach two full years of the COVID-19 pandemic, we now know it spreads primarily through airborne transmission. The virus rides inside tiny microscopic droplets or aerosol ejected from our mouths when we speak, shout, sing, cough, or sneeze. It then floats within the air, where it can be inhaled by and transmitted. This inspired researchers in India to explore how we can better understand and engineer airflow to mitigate the transmission of COVID-19.

   
Released: 1-Nov-2021 4:10 PM EDT
Cellular Quality-Control System Identified as a Culprit in Coronavirus Infection
Pacific Northwest National Laboratory

The unfolded protein response plays a key role in how Middle East Respiratory Syndrome damages the lungs. MERS is much less common but much lethal than COVID-19, which is also caused by a coronavirus.

   
Released: 29-Oct-2021 7:00 AM EDT
16-Year-Old with Cystic Fibrosis Receives Double Lung Transplant, a First for Hassenfeld Children’s Hospital at NYU Langone
NYU Langone Health

Hassenfeld Children’s Hospital at NYU Langone and the NYU Langone Transplant Institute reached a historic, first-ever milestone when surgeons replaced the lungs of a 16-year-old girl with cystic fibrosis.

Newswise: An old drug saves lives of COVID-19 patients
26-Oct-2021 5:25 PM EDT
An old drug saves lives of COVID-19 patients
McMaster University

McMaster researcher Edward Mills and his team treated 739 randomly selected Brazilian COVID-19 patients with fluvoxamine, with another 733 receiving a placebo, between Jan. 15 to Aug. 6 of this year. Every patient who received fluvoxamine during the trial was tracked for 28 days to determine their health outcomes and if they still need hospital treatment. Researchers found about a 30 per cent reduction in hospitalizations among those receiving fluvoxamine compared to those receiving the placebo.

Newswise: Pulmonary Fibrosis Foundation Position Statement Recommends Addressing Palliative Care Early in Patient Journey
Released: 26-Oct-2021 10:20 AM EDT
Pulmonary Fibrosis Foundation Position Statement Recommends Addressing Palliative Care Early in Patient Journey
Pulmonary Fibrosis Foundation

New Pulmonary Fibrosis Foundation (PFF) position statement advises that pulmonologists who treat patients with pulmonary fibrosis (PF) explore palliative care resources available in their communities to facilitate early referral and better quality of life.

Newswise: ASTRO 2021: New Study from Memorial Sloan Kettering Finds Targeted Radiation Beneficial in Cases of Advanced Lung Cancer
Released: 25-Oct-2021 6:20 PM EDT
ASTRO 2021: New Study from Memorial Sloan Kettering Finds Targeted Radiation Beneficial in Cases of Advanced Lung Cancer
Memorial Sloan Kettering Cancer Center

A new study from Memorial Sloan Kettering Cancer Center found that high-dose radiation therapy administered alongside systemic therapy in patients with metastatic non-small cell lung cancer can help extend progression free survival. This is the first and largest randomized clinical trial ever to study the use of stereotactic body radiation therapy (SBRT) in treating oligoprogressive metastatic lung and breast cancers. These findings will be presented during this year’s American Society for Radiation Oncology (ASTRO) meeting in Chicago.

Released: 25-Oct-2021 6:15 PM EDT
MD Anderson Research Highlights: ASTRO 2021 Special Edition
University of Texas MD Anderson Cancer Center

This special edition features oral presentations by MD Anderson researchers at the 2021 American Society for Radiation Oncology (ASTRO) Annual Meeting (Oct. 24-27) on novel therapeutic and diagnostic approaches, including partial breast irradiation, evaluating PD-L1 levels as biomarkers to better predict response to immunotherapy, and deep learning and biomechanical models.

25-Oct-2021 12:05 AM EDT
Intervention eliminates Black-white gaps in survival from early-stage breast and lung cancer
American Society for Radiation Oncology (ASTRO)

A new study shows that system-level changes to the way cancer care is delivered can also eliminate Black-white disparities in survival from early-stage lung and breast cancer. By identifying and addressing obstacles that kept patients from finishing radiation treatments for cancer, the intervention improved five-year survival rates for all patients and erased the survival gap between Black and white patients. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Newswise:Video Embedded virtual-lung-cancer-screening-is-just-as-effective-as-in-person-screening
VIDEO
20-Oct-2021 1:00 PM EDT
Virtual lung cancer screening is just as effective as in-person screening
American College of Surgeons (ACS)

A novel telemedicine lung cancer screening effort during the COVID-19 pandemic shows that virtual single-visit screenings are just as effective as single-visit screenings done in person at the hospital.

Released: 22-Oct-2021 11:40 AM EDT
Shape of virus may determine RSV infection outcomes
Washington University in St. Louis

Using a novel technology, the lab of Michael Vahey at the McKelvey School of Engineering uncovered shape-shifting properties of a common respiratory virus.

Released: 21-Oct-2021 12:50 PM EDT
Lower Airways Are Distinct in Cystic Fibrosis Even at Younger Ages
Ann and Robert H. Lurie Children's Hospital of Chicago

In the largest study of its kind, researchers found that the lower airways in children with cystic fibrosis (CF) have a higher burden of infection, more inflammation and lower diversity of microorganisms, compared to children with other illnesses who also have lung issues. They noted a clear divergence in these bacterial communities in toddlers, which is typically before progressive lung disease takes hold in patients with CF. Their findings, published in the journal PLOS ONE, could help providers target specific pathogens earlier, treat them and potentially prevent more severe lung disease.

Newswise: Lactoferrin supplements could aid in the recovery of COVID19 & other Respiratory Tract Infections
Released: 20-Oct-2021 3:15 PM EDT
Lactoferrin supplements could aid in the recovery of COVID19 & other Respiratory Tract Infections
University of Huddersfield

THE antiviral properties of lactoferrin makes it a great natural supplement that could also be used as an adjunct for COVID-19 and for various other Respiratory Tract Infections (RTIs) according to a team of researchers led by the University of Huddersfield.

Newswise: Biomarker Discovery Can Lead to Improved Diagnosis and Treatment of Asthma and COPD
Released: 20-Oct-2021 12:05 PM EDT
Biomarker Discovery Can Lead to Improved Diagnosis and Treatment of Asthma and COPD
Rutgers University-New Brunswick

Rutgers researchers have discovered that people with asthma and chronic obstructive pulmonary disease have a protein in their lungs that leaks a small molecule into their bloodstream that restricts their breathing instead of relaxing their airways.

Released: 19-Oct-2021 11:40 AM EDT
UC San Diego Study: E-cigarettes Don’t Help Smokers Stay Off Cigarettes
University of California San Diego

E-cigarette use did not help smokers quit and may make smokers more likely to relapse, according to a study by Herbert Wertheim School of Public Health and Human Longevity Science at University of California San Diego and Moores Cancer Center.

Newswise: Critical Care and Pulmonary Societies Encourage Flu Shots Amid COVID-19 Spread
Released: 19-Oct-2021 10:20 AM EDT
Critical Care and Pulmonary Societies Encourage Flu Shots Amid COVID-19 Spread
American Thoracic Society (ATS)

The members of the Critical Care Societies Collaborative, which includes the American Association of Critical-Care Nurses, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine, strongly urge individuals to get vaccinated against the COVID-19 virus and to receive their influenza (flu) immunizations for the upcoming flu season.

Released: 18-Oct-2021 10:40 AM EDT
Will There Be a Twindemic?
Global Virus Network

“Twindemic” is a term that has not yet been in the headlines but is likely to become part of our lexicon as the summer progresses.

Released: 15-Oct-2021 1:55 PM EDT
Daily use of cannabidiol (‘CBD’) oil may be linked to lung cancer regression
BMJ

It may be worth exploring further the use of cannabidiol (‘CBD’) oil as a potential lung cancer treatment, suggest doctors in BMJ Case Reports after dealing with a daily user whose lung tumour shrank without the aid of conventional treatment.

Released: 14-Oct-2021 12:35 PM EDT
High Ferritin in Severe Covid-19 Pneumonia is Linked to Improved Outcomes After Steroid Treatment
Stony Brook University

Physicians from the Renaissance School of Medicine at Stony Brook University discovered that for patients with severe Covid-19 pneumonia who had higher ferritin in their blood and were treated with a corticosteroid, fewer intubations and deaths resulted. Their findings are reported in JAMA Network Open.

Released: 14-Oct-2021 10:00 AM EDT
The Medical Minute: What parents need to know about a rise in RSV
Penn State Health

After a year of COVID-19 precautions that saw virtually no cases of this common childhood illness, respiratory syncytial virus – or RSV – is back with a vengeance, and health care professionals are concerned.

Released: 13-Oct-2021 1:30 PM EDT
Claims E-cigarettes Are a Harm Reduction Tool Unproven;
American Thoracic Society (ATS)

Oct. 13, 2021 – “The ATS reiterates our long-held position – e-cigarettes are not ‘safe’ and the claims that e-cigarettes are a harm reduction tool remain unproven. All e-cigarettes have significant health risks including nicotine addiction and respiratory disease,” said ATS President Lynn Schnapp, MD, ATSF.

12-Oct-2021 12:55 PM EDT
How many people get ‘long COVID?’ More than half, researchers find
Penn State College of Medicine

More than half of the 236 million people who have been diagnosed with COVID-19 worldwide since December 2019 will experience post-COVID symptoms — more commonly known as “long COVID” — up to six months after recovering, according to Penn State College of Medicine researchers.

Released: 13-Oct-2021 10:05 AM EDT
Russell lab wins grant to develop new tuberculosis drugs
Cornell University

A faculty member at the College of Veterinary Medicine has received funding to improve the efficacy of medicines against one of the world’s most dangerous infectious diseases.

Released: 12-Oct-2021 11:45 AM EDT
SARS-COV-2, Children, and Multi-Inflammatory Syndrome
Global Virus Network

With the advent of the school year and children returning to in-person classes, there comes a concern over consequences with respect to the spread of the highly contagious Delta variant. It has been accepted that children are not as susceptible to viral infection and severe illness as adults. However, the current prevalence of the Delta variant is producing different outcomes.

11-Oct-2021 3:25 PM EDT
Common respiratory virus manipulates immune genes to protect itself
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have discovered that the viral protein NS1 from respiratory syncytial virus (RSV) alters the activity of immune genes, sabotaging the immune response to RSV infection.

Released: 12-Oct-2021 8:40 AM EDT
Worsening depression cuts survival in lung cancer patients
Ohio State University

Lung cancer patients whose symptoms of depression got worse after diagnosis died significantly earlier than those whose symptoms stayed the same or improved, a new study shows.

4-Oct-2021 2:00 PM EDT
More than one in five opioid-naïve patients still use opioids three months after surgery
American Society of Anesthesiologists (ASA)

Smokers, those with bipolar disorder, depression, pulmonary hypertension at higher risk for persistent opioid use, study finds.

Newswise:Video Embedded will-flu-season-be-bad-this-year
VIDEO
Released: 5-Oct-2021 12:05 PM EDT
Will Flu Season Be Bad This Year?
Cedars-Sinai

The flu seemed to vanish in 2020 as safety measures meant to stop the spread of COVID-19 also worked against the influenza virus. But with some precautions lifted amid widespread vaccination, what will it mean for this year's flu season?

Released: 5-Oct-2021 9:00 AM EDT
Researchers from CHOP, Penn receive $5.3 million grant to reduce unnecessary hospital monitoring practices
Children's Hospital of Philadelphia

Researchers have received a $5.3 million grant to conduct the Eliminating Monitor Overuse (EMO) clinical trial, seeking to discover how best to reduce the overuse of unnecessary monitoring strategies for infants who have a common lung infection called bronchiolitis.

Newswise: Mitigating lung damage, mortality due to SARS-CoV-2
Released: 5-Oct-2021 8:45 AM EDT
Mitigating lung damage, mortality due to SARS-CoV-2
University of Illinois Chicago

Researchers report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans.

Newswise: World-first: experts at UHN, Sinai Health and SickKids develop plan to save critically ill mother and her baby
Released: 4-Oct-2021 8:25 AM EDT
World-first: experts at UHN, Sinai Health and SickKids develop plan to save critically ill mother and her baby
University Health Network (UHN)

Physicians recommend that patients with pulmonary hypertension avoid pregnancy, given the high risk of death for the mother and baby. However, Candice Cruise was unaware of her condition until she reached 21 weeks of pregnancy.

Released: 30-Sep-2021 6:15 PM EDT
Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs
Washington University in St. Louis

A new study from Washington University School of Medicine in St. Louis estimates that 78% to 92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patient’s tumor.

Released: 30-Sep-2021 2:40 PM EDT
Differentiating between COVID-19 and chronic rhinosinusitis
University of Alabama at Birmingham

UAB’s Jessica Grayson, M.D., clears the confusion on how to tell COVID-19 from other respiratory illnesses.

Released: 30-Sep-2021 12:15 PM EDT
Wayne State’s Department of Emergency Medicine secures $15.88 million from CDC to study viral infection surveillance
Wayne State University Division of Research

The U.S. Centers for Disease Control and Prevention has awarded $15.88 million to the Wayne State University School of Medicine’s Department of Emergency Medicine to be the epicenter of a national study on viral infections that present in emergency departments across the county.

Released: 30-Sep-2021 8:30 AM EDT
NCCN Publishes New Guide to Improving Knowledge and Quality of Life for Small Cell Lung Cancer Patients
National Comprehensive Cancer Network® (NCCN®)

NCCN announces the publication of new NCCN Guidelines for Patients®: Small Cell Lung Cancer (SCLC), which is a neuroendocrine tumor type of lung cancer that is linked to smoking and tends to be aggressive. This guide is free to view or download at NCCN.org/patientguidelines and is funded by NCCN Foundation®.

29-Sep-2021 7:05 AM EDT
ECMO life support offers sickest COVID-19 patients a chance to survive, but a slimmer one than once thought
Michigan Medicine - University of Michigan

The life-support system called ECMO can rescue COVID-19 patients from the brink of death, but not at the rates seen early in the pandemic, a new international study finds. Where once about 60% of such patients survived at least 90 days in spring 2020, by the end of the year it was just under half.

Newswise: On World Lung Day FIRS Calls for Global Investment in Respiratory Health
24-Sep-2021 2:15 PM EDT
On World Lung Day FIRS Calls for Global Investment in Respiratory Health
American Thoracic Society (ATS)

Today, on World Lung Day (WLD), members of the Forum of International Respiratory Societies (FIRS) and WLD partner organizations, such as the American Thoracic Society, are calling for respiratory health to be a top priority in global decision-making beyond the COVID-19 pandemic.

   
Newswise:Video Embedded what-is-rsv-and-how-can-i-protect-my-children
VIDEO
Released: 24-Sep-2021 11:15 AM EDT
What is RSV? And How Can I Protect My Children?
Cedars-Sinai

Respiratory syncytial virus, commonly called RSV, usually affects very young children in the winter months. But this year, physicians are treating an unusual, out-of-season surge both in California and across the country.

Newswise: Scientists Pinpoint Problem Protein in Mucus
Released: 22-Sep-2021 3:15 PM EDT
Scientists Pinpoint Problem Protein in Mucus
University of North Carolina School of Medicine

This discovery, published in the Proceedings of the National Academy of Sciences (PNAS), suggest that MUC5AC could become a target of better therapeutics to untangle the super thick and sticky mucus that plays a role in health problems for millions of people suffering from pulmonary conditions.



close
1.82446